Transient tachypnoea of newborn. Transient tachypnoea of newborn
Conditions
Interventions
Intervention 1: Intervention group: Salbutamol Glasco Compani product ./1 mg/kg with 2 milliliter saline nebulization /6 hour for 24 hours. Intervention 2: Control group: 2 milliliter saline nebulizat
Treatment - Drugs
Placebo
Intervention group: Salbutamol Glasco Compani product ./1 mg/kg with 2 milliliter saline nebulization /6 hour for 24 hours
Control group: 2 milliliter saline nebulizationGhazi pharmaceutical company/6 hour for 24 hours
Sponsors
Vice chancellor for research,Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 1 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term/near term neonates with transient tachypnea of newborn; without Sepsis; pneumonia; congenital heart disease; Pulmonary hypertension. Exclusion criteria: Preterm neonates with Respiratory distress syndrome; pneumonia; sepsis; surfactant requirement.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Admission durations. Timepoint: during study and drug injection every 6 hour. Method of measurement: days.;CPAC application hours. Timepoint: primary 24 hours. Method of measurement: hour.;Mechanical ventilation application hours. Timepoint: primary 24 hours. Method of measurement: hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arrhymia. Timepoint: during study. Method of measurement: cardiac monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMousavi Mirhadi
Tabriz University of Medical Sciences
Outcome results
None listed